Morgan Stanley owned 0.17% of GlaxoSmithKline PLC worth $171,939,000 as of its most recent filing with the SEC. Park National Corp OH now owns 6,314 shares of the pharmaceutical company's stock worth $266,000 after buying an …
Dear Mr. Berko: My broker has recommended that I invest $20,000 and buy 500 shares of GlaxoSmithKline, a world-class drug company. The dividend is $2.48 and that yields a very attractive 5.9 percent He thinks Glaxo's problems are …
Law360, Miami (July 8, 2016, 9:39 PM EDT) -- Stiefel Laboratories Inc. pushed back Friday in Florida federal court against the U.S. Securities and Exchange Commission's bid for a win on claims that the pharmaceutical company and its ex …
StockMarketWire.com - ViiV Healthcare, owned by GlaxoSmithKline, has announced positive interim results from the DAWNING study, modified to allow patients the opportunity to receive dolutegravir-based regimens. This is a non …
Guardian Investment Management increased its ownership in GlaxoSmithKline PLC by 2.4% in its quarterly SEC …
But in the stock market today, Gilead stock slipped a fraction to 67.55, while GlaxoSmithKline edged up 0.3% to 40.11. On Friday, Gilead stock touched its lowest price since April 2014, at 65.43. 8/11/2017 Biotech stocks were on the …
GlaxoSmithKline Consumer Healthcare Ltd. is engaged in the business of manufacturing nutritional products. Its products include Horlicks, Boost, Viva, Maltova, Ostocalcium, Otrivin, Sensodyne, Voltaren, ActiBase, ActiGrow and …
Analysis a someone baked according such in individuals could an in patients of ways rats, office set GSK researchers those mix was and farm lead more well at …
Graham Spooner, investment research analyst at The Share Centre, picks pharmaceutical research company GlaxoSmithKline as stock of the week. Research based pharmaceutical company, GlaxoSmithKline, has …